Article

Novel imaging platform first to offer simultaneous cSLO, SD-OCT imaging

A novel retinal imaging tool combining confocal scanning laser ophthalmoscopy (cSLO) with high-resolution spectral-domain optical coherence tomography (SD-OCT) allows for the first time simultaneous imaging with cSLO (including angiography and autofluorescence) and SD-OCT.

Key Points

Frank G. Holz, MD, and colleagues at the University of Bonn in Germany described the features of the technology and presented images acquired using the dual platform in patients with various macular pathologies, including early, atrophic, and exudative age-related macular degeneration (AMD) and retinal vascular occlusions.

The device offers five cSLO imaging modes: fluorescein angiography, indocyanine green angiography, fundus autofluorescence, infrared, and redfree, any of which can be combined with simultaneous SD-OCT. The SD-OCT acquires 40,000 A-scans/second with a 7-µm depth and 14-µm lateral resolution. B-scans obtained with the SD-OCT system encompass an angle of 30° at a scan width of 1.536 (or 768) A-scans, lateral resolution of 6 (or 11) µm/pixel digital at a scan rate of 26 (or 50) B-scans/sec. The system also incorporates automated eye-tracking to adjust for any eye movement.

"With its high speed, the SD-OCT affords more comprehensive coverage of the retina, can generate 3-D images, and allows testing to be completed more quickly with reduced sampling errors from motion artifact," Dr. Holz said. "The high-transverse pixel density images acquired allow visualization of retinal ultrastructure from the internal limiting membrane to the retinal pigment epithelium cell/choriocapillaris. Such finely detailed images enable precise localization of intraretinal diseases and visualization of specific pathologic features."

Images presented in the poster depicted the clarity of vessel microarchitecture in an eye with exudative AMD and showed how the anatomic pathology correlated with leakage on fluorescein angiography.

"The instrument also allows for exact alignment of images obtained at different time points and, therefore, serial measurements of retinal thickness in SD-OCT cross-sections at precisely the same anatomic locations," Dr. Holz said. "In comparison with previous OCT techniques without the possibility of alignment, this feature will help clinicians to decide whether or not a reinjection is necessary in a patient treated with an intravitreal anti-VEGF agent."

In an eye with early AMD, the subconfluent soft drusen could be seen clearly in the SD-OCT image beneath the hyperreflective retinal pigment epithelium, and corresponding alterations on fundus autofluorescence were visualized on simultaneously acquired cSLO frames. In another example, the morphologic substrates of well-defined increased fundus autofluorescence signals in the junctional zone of areas with geographic atrophy were visualized at outer retinal layers.

A cSLO fundus autofluorescence image obtained in a patient with a recent branch retinal artery occlusion showed a decreased autofluorescence signal that correlated with features visible on funduscopy. Hyperreflectivity and swelling of the inner neurosensory retinal layers with a shadowing effect of posterior structures could be seen in an SD-OCT image. In a cross-section SD-OCT scan, the impacted calcified embolus in the retinal vessel could be visualized as a hyperreflective structure.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
© 2025 MJH Life Sciences

All rights reserved.